Barrett Esophagus
📧 Sign up to get email alerts when something new happens for Barrett Esophagus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-10-22Clinical Trial Update: Imaging of the Esophagus Using a SECM Capsule [NA]
A clinical trial evaluating imaging of the esophagus using a SECM capsule was withdrawn; no results or phase information were reported.
-
CLINICAL_TRIALS withdrawal · 2025-03-27Clinical Trial Update: Barretts oEsophageal Resection With Steroid Therapy Trial [Phase 4]
Phase 4 clinical trial on Barrett's esophagus with steroid therapy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-05-09Clinical Trial Update: Case Analysis on Real Life Incidence of Photodynamic Therapy (PDT) Safety Outcomes
A withdrawn clinical trial update analyzing real-life safety outcomes of photodynamic therapy in esophageal cancer, lung cancer, and Barrett…
-
CLINICAL_TRIALS withdrawal · 2012-05-08Clinical Trial Update: Safety of Photodynamic Therapy (PDT) in the Ablation of High-grade Dysplasia (HGD) in Barrett's Esophagus (BE) [Phase 3]
A Phase 3 trial evaluating safety of photodynamic therapy to ablate high-grade dysplasia in Barrett's esophagus has been withdrawn.
-
EMA withdrawal · 2012-05-07EMA Withdrawn: PhotoBarr (porfimer sodium) — Pinnacle Biologics B.V.
The EMA withdrew PhotoBarr (porfimer sodium) from the market.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.